Clinical Trials Logo
  1. Home
  2. Other
  3. NCT04250207

Study to Investigate the Safety and Efficacy of K-321 in Patients With Fuchs Endothelial Corneal Dystrophy (FECD) Following Descemetorhexis

Fuchs' Endothelial Corneal Dystrophy Clinical Trial

Official title:
A Double-Masked, Randomised, Placebo-Controlled, Parallel-Group, 12 Week, Phase 2 Study to Investigate the Safety and Efficacy of K-321 Eye Drops After Descemetorhexis in Patients With Fuchs Endothelial Corneal Dystrophy

Clinical Trial Summary

The objective of this study is to investigate the effect of K-321 in patients with Fuchs endothelial corneal dystrophy (FECD) after descemetorhexis.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04250207
Study type Interventional
Source Kowa Research Institute, Inc.
Contact
Status Completed
Phase Phase 2
Start date June 23, 2020
Completion date June 27, 2022
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT02020044 - Outcome After Descemet Membrane Endothelial Keratoplasty (DMEK) and Ultra-thin Descemet Stripping Automated Endothelial Keratoplasty (DSAEK) N/A
Completed NCT01979250 - Fuchs' Endothelial Dystrophy: Clinical Characteristics, Treatment Outcome, and Pathology N/A
Completed NCT05531760 - Predictive Factors of Graft Detachment Following Dmek
Recruiting NCT04175938 - Assessment of Corneal Endothelial Function Following Hypoxic Stress Phase 1/Phase 2
Completed NCT00800111 - Study of Endothelial Keratoplasty Outcomes N/A